5.65

0.35% -0.02

908 Devices Inc (MASS)

Overview News Price History Option Chain Financials Discussions Forecast

908 Devices Inc stock is currently priced at $5.65, with a 24-hour trading volume of 253.07K. It has seen a -0.35% decreased in the last 24 hours and a -14.52% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $5.63 pivot point. If it approaches the $5.78 resistance level, significant changes may occur.

Previous Close:

$5.67

Open:

$5.86

24h Volume:

253.07K

Market Cap:

$194.81M

Revenue:

$50.23M

Net Income/Loss:

$-36.40M

P/E Ratio:

-4.7479

EPS:

-1.19

Net Cash Flow:

$-27.10M

1W Performance:

-0.35%

1M Performance:

-14.52%

6M Performance:

-14.13%

1Y Performance:

-13.74%

1D Range:

$5.60

$6.07

52W Range:

$4.85

$12.51

908 Devices Inc Stock (MASS) Company Profile

Name

908 Devices Inc

Sector

Healthcare (1213)

Industry

Medical Devices (160)

Phone

857 254 1500

Address

645 Summer Street, Boston

Employee

Twitter

Next Earnings Date

2024-04-30

Latest SEC Filings

MASS's Discussions on Twitter

908 Devices Inc Stock (MASS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-07-23	Initiated	Stephens	Overweight
Oct-15-21	Resumed	Cowen	Outperform
Jan-12-21	Initiated	Cowen	Outperform
Jan-12-21	Initiated	SVB Leerink	Outperform
Jan-12-21	Initiated	Stifel	Buy
Jan-12-21	Initiated	William Blair	Outperform

View All

908 Devices Inc Stock (MASS) Latest News

Cathie Wood Sells $13.15M Worth Of Coinbase Shares Amid Bitcoin Flirting With All-Time High Levels — Shops For Palantir Stock Instead

Benzinga

Cathie Wood Sells $13.15M Worth Of Coinbase Shares Amid Bitcoin Flirting With All-Time High Levels — Shops For Palantir Stock Instead

Benzinga

Nevro (NVRO) Reports Q4 Loss, Tops Revenue Estimates

Zacks Investment Research

908 Devices Inc Stock (MASS) Financials Data

908 Devices Inc (MASS) Revenue 2024

MASS reported a revenue (TTM) of $50.23 million for the quarter ending December 31, 2023, a +7.21% rise year-over-year.

908 Devices Inc (MASS) Net Income 2024

MASS net income (TTM) was -$36.40 million for the quarter ending December 31, 2023, a -8.45% decrease year-over-year.

908 Devices Inc (MASS) Cash Flow 2024

MASS recorded a free cash flow (TTM) of -$27.10 million for the quarter ending December 31, 2023, a -17.97% decrease year-over-year.

908 Devices Inc (MASS) Earnings per Share 2024

MASS earnings per share (TTM) was -$1.13 for the quarter ending December 31, 2023, a -5.61% decline year-over-year.

908 Devices Inc Stock (MASS) Insider Trading

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total
Brown Christopher D.	Chief Product Officer	Apr 01 '24	Option Exercise	1.75	3,600	6,300	884,994
Griffith Joseph H. IV	Chief Financial Officer	Mar 26 '24	Option Exercise	1.58	8,437	13,330	93,437
Griffith Joseph H. IV	Chief Financial Officer	Feb 02 '24	Sale	7.09	9,711	68,873	80,000
Knopp Kevin J.	President and CEO	Feb 01 '24	Sale	7.00	9,071	63,461	411,981
Griffith Joseph H. IV	Chief Financial Officer	Feb 01 '24	Sale	7.00	5,698	39,892	89,711
Turner Michael S.	Chief Legal & Admin Officer	Feb 01 '24	Sale	6.99	5,232	36,559	9,105
Brown Christopher D.	Chief Product Officer	Feb 01 '24	Sale	7.01	3,957	27,730	886,394
Griffith Joseph H. IV	Chief Financial Officer	Dec 28 '23	Sale	12.08	6,000	72,480	80,000
Brown Christopher D.	Chief Product Officer	Dec 21 '23	Sale	9.12	7,370	67,214	877,905
Brown Christopher D.	Chief Product Officer	Dec 20 '23	Sale	9.10	5,235	47,638	885,275

908 Devices Inc. develops and sells measurement devices for chemical and biochemical analysis in the United States, China, Japan, Europe, and internationally. The company develops its products using mass spectrometry (Mass Spec) technology, an analytical technique for molecular analysis. It offers handheld and desktop Mass Spec devices for the point-of-need applications in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. 908 Devices Inc. was founded in 2012 and is headquartered in Boston, Massachusetts.